Medication use during pregnancy and lactation: An urgent call for public health action

被引:58
|
作者
Lagoy, CT [1 ]
Joshi, N [1 ]
Cragan, JD [1 ]
Rasmussen, SA [1 ]
机构
[1] Natl Ctr Birth Defects & Developmental Disabil, Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
10.1089/jwh.2005.14.104
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Questions about medication use during pregnancy and lactation are a concern for women and healthcare providers. Unfortunately, there is little experience with the use of most medications in human pregnancy and lactation at the time they are marketed. Even when information is available, it may not be readily accessible to women and healthcare providers. Nevertheless, medication use by pregnant and breastfeeding women may be beneficial, and even essential, to ensure the health of both mother and child. In addition, almost half of pregnancies in the United States each year are unintended, and medication exposures may occur in the early weeks of gestation before a pregnancy is recognized. For these reasons, it is critical that up-to-date information about the effects of medication use during pregnancy and lactation and the management of maternal conditions be available to women and healthcare providers. A comprehensive, coordinated public health approach that builds on and expands existing activities is needed to generate information about medication use, make that information readily available, and translate it into safe and effective healthcare. Critical components of this system include a central source of up-to-date information, further development and coordination of monitoring and research activities, the availability of counseling services throughout the country, development of standard communication messages, and a panel of experts to provide oversight. This will require collaborative support from government agencies, nonprofit organizations, academic and public health professionals, and healthcare providers to ensure safe and beneficial use of medications during pregnancy and lactation.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 50 条
  • [1] Medication Use During Pregnancy and Lactation: Introducing the Pregnancy and Lactation Labeling Rule
    Dinatale, Miriam
    Sahin, Leyla
    Johnson, Tamara
    Howard, Tammie Brent
    Yao, Lynne
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2017, 30 (02) : 132 - 134
  • [3] Medication Use During Pregnancy and Lactation in a Dutch Population
    de Waard, Marita
    Blomjous, Birgit S.
    Hol, Marinka L. F.
    Sie, Sintha D.
    Corpeleijn, Willemijn E.
    van Goudoever, Johannes B.
    van Weissenbruch, Mirjam M.
    JOURNAL OF HUMAN LACTATION, 2019, 35 (01) : 154 - 164
  • [4] Prevalences and trends in medication use during pregnancy and lactation
    Gendron, Marie-Pierre
    Martin, Brigitte
    Oraichi, Driss
    Berard, Anick
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S111 - S112
  • [5] Medication use in the treatment of migraine during pregnancy and lactation
    Sylvia Lucas
    Current Pain and Headache Reports, 2009, 13 : 392 - 398
  • [6] Medication use in the treatment of migraine during pregnancy and lactation
    Lucas, Sylvia
    CURRENT PAIN AND HEADACHE REPORTS, 2009, 13 (05) : 392 - 398
  • [7] Antibiotic Resistance in the Philippines: A Public Health Crisis and Call for Urgent Action
    Corpuz, Jeff Clyde G.
    HEALTH SCIENCE REPORTS, 2025, 8 (03)
  • [8] An Urgent Call for Public Health Firefighters
    Chaulk, C. Patrick
    Zenilman, Jonathan
    Bialek, Ron
    Rompalo, Anne
    JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2021, 27 (03): : 322 - 324
  • [9] ACOG guidelines on psychiatric medication use during pregnancy and lactation
    Armstrong, Carrie
    AMERICAN FAMILY PHYSICIAN, 2008, 78 (06) : 772 - +
  • [10] Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation
    Gendron, Marie-Pierre
    Martin, Brigitte
    Oraichi, Driss
    Berard, Anick
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (05) : 523 - 531